𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radioactive phosphorus. II. In the treatment of myeloid leukemia

✍ Scribed by Henry D. Diamond; Lloyd F. Craver

Publisher
John Wiley and Sons
Year
1951
Tongue
English
Weight
820 KB
Volume
4
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Progress in the treatment of acute myelo
Progress in the treatment of acute myeloid leukemia
✍ Farhad Ravandi; Alan K. Burnett; Edward D. Agura; Hagop M. Kantarjian πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi

Gemtuzumab ozogamicin in the treatment o
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
✍ Francis Giles; Elihu Estey; Susan O'Brien πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 484 KB πŸ‘ 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized anti‐CD33 antibody (hP67.6) linked to N‐acetyl‐γ calicheamicin 1,2‐dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration

Treatment of acute myeloid leukemia in t
Treatment of acute myeloid leukemia in the elderly: A clinical dilemma
✍ Dr. J. A. Copplestone; A. G. Smith; C. Osmond; D. G. Oscier; T. J. Hamblin πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 530 KB

Fifty-four patients representing all the cases of acute myeloid leukemia in patients aged over 60 years, presenting to three adjacent hospitals, were studied. Only 26 of the 54 patients were considered suitable for remission induction with intensive combination chemotherapy which produced seven comp